Travere Therapeutics, Inc. (TVTX)

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $114.45M in the quarter ending June 30, 2025, with 111.49% growth. This brings the company's revenue in the last twelve months to $333.87M, up 87.94% year-over-year. In the year 2024, Travere Therapeutics had annual revenue of $233.18M with 60.55% growth.

• Revenue (ttm): $333.87M
• Revenue Growth: +87.94%
• P/S Ratio: 6.18
• Revenue / Employee: $867,182
• Employees: 385
• Market Cap: 2.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	233.18M	87.94M	60.55%
Dec 31, 2023	145.24M	35.78M	32.69%
Dec 31, 2022	109.46M	-22.38M	-16.97%
Dec 31, 2021	131.84M	-66.49M	-33.52%
Dec 31, 2020	198.32M	22.98M	13.11%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.